Suppr超能文献

羟氯喹在皮肤科及其他领域的最新进展

Hydroxychloroquine in Dermatology and Beyond: Recent Update.

作者信息

Sardana Kabir, Sinha Surabhi, Sachdeva Soumya

机构信息

Department of Dermatology, STD and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) (PGIMER), Dr. Ram Manohar Lohia Hospital, New Delhi, India.

出版信息

Indian Dermatol Online J. 2020 May 10;11(3):453-464. doi: 10.4103/idoj.IDOJ_280_20. eCollection 2020 May-Jun.

Abstract

Hydroxychloroquine is one of the most frequently used drugs in dermatology with a wide variety of uses due to its immunomodulatory, anti-inflammatory, photoprotective, and metabolic actions and low side effect profile. Demonstration of its antiviral action has led to renewed interest by physicians worldwide during the ongoing coronavirus disease of 2019 (COVID-19) pandemic. Like its immunomodulatory action, its antiviral activity is also due to its ability to alkalinize the intracytoplasmic milieu, leading to disordered viral entry/fusion and deranged viral protein synthesis. However, randomized controlled trials are the need of the hour to conclusively determine its clinical efficacy in such infections. A review of the multitude of mechanisms of action, updated screening and monitoring guidelines, drug interactions, side effects, and its use in special populations is described.

摘要

羟氯喹是皮肤科最常用的药物之一,因其免疫调节、抗炎、光保护和代谢作用以及低副作用而有广泛用途。在2019年冠状病毒病(COVID-19)大流行期间,其抗病毒作用的证明引起了全球医生的新关注。与其免疫调节作用一样,其抗病毒活性也归因于它使胞质内环境碱化的能力,从而导致病毒进入/融合紊乱和病毒蛋白合成失调。然而,目前迫切需要进行随机对照试验,以最终确定其在此类感染中的临床疗效。本文描述了对其多种作用机制、最新筛查和监测指南、药物相互作用、副作用及其在特殊人群中的应用的综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc61/7367590/5ccb942d4578/IDOJ-11-453-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验